APA (7th ed.) Citation

Capone, A., Carbone, M. L., Mastroeni, S., Di Pietro, F. R., Verkhovskaia, S., Morese, R., . . . Failla, C. M. (2026). Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis. Cancers, 18(7), 1072. https://doi.org/10.3390/cancers18071072

Chicago Style (17th ed.) Citation

Capone, Alessia, et al. "Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis." Cancers 18, no. 7 (2026): 1072. https://doi.org/10.3390/cancers18071072.

MLA (9th ed.) Citation

Capone, Alessia, et al. "Immune-Related Adverse Events in Patients with Melanoma Treated with B-RAF/MEK Target Therapy: Occurrence and Circulating Immune Cell Analysis." Cancers, vol. 18, no. 7, 2026, p. 1072, https://doi.org/10.3390/cancers18071072.